Single Cell Bioinformatics Software and Services Market Size, Share & Trends Analysis Report By Product Type (Software Solutions, Services), By Applications (Oncology, Immunology, Neurology, Stem Cell Research), By Technology (Next-Generation Sequencing (NGS), Mass Cytometry, Single-Molecule Real-Time (SMRT) Sequencing), By End-User (Academic Institutes, Pharmaceutical Companies, Contract Research Organizations (CROs)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Tejas Zamde | Format:

Single-Cell Bioinformatics Software and Services Market Size

The global single cell bioinformatics software and services market size was valued at USD 1.41 billion in 2025 and is projected to grow from USD 1.58 billion in 2026 to USD 4.04 billion by 2034, registering a CAGR of 12.4% during the forecast period from 2026 to 2034. North America dominated the single cell bioinformatics software and services market with a market share of 42.5% in 2025.

Single-cell bioinformatics software and services are revolutionizing molecular biology by providing high-resolution insights into cellular heterogeneity. These technologies enable the analysis of individual cells, revealing intricate details about their genetic, transcriptomic, and proteomic profiles.

This sector's growth is driven by significant advancements in single-cell sequencing technologies, which facilitate the exploration of complex biological systems at an unprecedented level of detail. The rising demand for personalized medicine is a key driver, as clinicians and researchers increasingly rely on single-cell analytics to develop treatments tailored to individual patients.

Moreover, the surge in bioinformatics tools designed to manage and analyze large, complex single-cell datasets has enhanced data integration, visualization, and interpretation. These innovations make single-cell technologies indispensable for cutting-edge research and clinical applications. Coupled with growing investments in life sciences research and the integration of AI, the market for single-cell bioinformatics is rapidly expanding.

Single Cell Bioinformatics Software and Services Market Size

Download a Free Sample To learn more about this report.

Integration of Ai and Machine Learning

AI and machine learning are revolutionizing bioinformatics by streamlining data interpretation, identifying critical biomarkers, and refining disease progression prediction models. Leading companies like 10x Genomics and Illumina are leveraging AI-driven software to analyze complex single-cell datasets, unlocking actionable biological insights.

These technologies enhance the precision and scalability of genomic studies, empowering researchers to decode cellular heterogeneity, uncover disease mechanisms, and accelerate the development of personalized therapies and diagnostic tools.

In June 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients with unprecedented accuracy.

This advancement exemplifies how AI can significantly improve genetic analysis and patient outcomes.

Increased Adoption of Cloud-Based Platforms

Cloud-based bioinformatics platforms offer unmatched scalability, allowing researchers to handle large, complex single-cell datasets without the limitations of local infrastructure. These platforms are cost-effective, reducing the need for expensive on-premises hardware and adopting pay-as-you-go models.

Moreover, they enhance collaboration by facilitating seamless data sharing and joint analysis among teams across different locations. This approach revolutionizes single-cell research and drives faster discoveries in genomics, transcriptomics, and precision medicine.

For example, in May 2024, QIAGEN launched QCI Secondary Analysis, a cloud-based SaaS solution for high-throughput secondary analysis compatible with any clinical next-generation sequencing (NGS) data.

This service supports all QIAGEN QIAseq panels and integrates with QCI Interpret for scalable and customizable workflows in oncology and inherited disease applications.

Product Insights

Software solutions are the market leader due to their vital role in enabling complex data analysis and visualization. Tools like 10x Genomics’ Loupe Browser and Illumina’s DRAGEN Bio-IT Platform are indispensable for efficiently processing large datasets. AI-powered platforms offer scalable, user-friendly interfaces that simplify data interpretation. The increasing demand for data-driven insights, along with the rising complexity of single-cell datasets, is driving growth in this subsegment, establishing software solutions as a dominant force in bioinformatics.

Single Cell Bioinformatics Software and Services Market Size By Segments

Request Customizationto receive a tailored report.

Applications Insights

Oncology holds the largest market share in single-cell bioinformatics, essential for studying tumor heterogeneity, discovering cancer biomarkers, and understanding the tumor microenvironment. Platforms like Bio-Rad’s Single-Cell Gene Expression Solutions are designed with high sensitivity and specificity and are tailored for cancer research. The global prevalence of cancer and the growing need for precision medicine in oncology research are key drivers of this subsegment’s rapid expansion, fueling further advancements and the adoption of single-cell technologies in oncology.

Technology Insights

Next-Generation Sequencing (NGS) is the fastest-growing technology in single-cell bioinformatics, widely used in transcriptomics and epigenomics. Platforms like 10x Genomics’ Chromium and Illumina’s NovaSeq provide high-throughput, high-resolution sequencing, enabling comprehensive single-cell analysis. The ability of NGS to generate extensive and detailed datasets makes it indispensable for modern research, driving its rapid adoption. The technology’s transformative impact on genomic research, particularly in single-cell sequencing, is propelling NGS to the forefront of bioinformatics innovation and growth.

End-User Insights

Academic and research institutions are the largest end-user base for single-cell bioinformatics, leading the charge in genomics research. Initiatives such as the Human Cell Atlas rely on bioinformatics tools to map cell types and states across tissues. Large-scale research funding and access to cutting-edge technology drive this segment's growth. Additionally, pharmaceutical companies are adopting single-cell bioinformatics for drug discovery and precision medicine. Contract Research Organizations (CROs) are also growing as they offer cost-effective solutions for bioinformatics outsourcing.

Single Cell Bioinformatics Software and Services Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds the largest market share in the global market, driven by its robust bioinformatics infrastructure, substantial funding for genomics research, and early adoption of cutting-edge technologies. Organizations like the NIH and Human Cell Atlas have committed significant resources to advancing single-cell genomics projects, further fueling growth.

Moreover, the region’s innovative ecosystem, which includes a strong network of academic institutions, biotechnology firms, and tech companies, fosters continuous advancements in bioinformatics solutions. Key market players such as 10x Genomics, Illumina, and Fluidigm operate prominently, benefiting from strong R&D capabilities.

For example, Illumina’s DRAGEN Bio-IT platform, developed in the U.S., is widely utilized for high-speed and accurate single-cell data processing, showcasing the region's leadership in bioinformatics innovation.
The U.S. stands at the forefront of the single-cell bioinformatics market, driven by substantial investments in biotechnology and a robust infrastructure supporting genomic research. The presence of leading bioinformatics firms and academic institutions fosters innovation and adoption of advanced single-cell analysis tools. Government initiatives, such as funding from the National Institutes of Health (NIH), further propel market growth.

North America Single Cell Bioinformatics Software and Services Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Single Cell Bioinformatics Software and Services Market Trends

Asia Pacific is experiencing the fastest growth in the single-cell bioinformatics market, fueled by rising healthcare expenditures, an increasing focus on precision medicine, and expanding R&D activities. China stands out as a major hub for genomics research, with significant government initiatives such as the Precision Medicine Initiative driving the market’s expansion. Japan is renowned for its advances in biotechnology and single-cell technologies, bolstered by a strong academic and industrial framework.

Meanwhile, India’s rapidly growing biotechnology sector and increasing collaborations between academia and industry further propel the region's development.

For instance, China-based BGI Genomics is heavily investing in single-cell sequencing platforms and bioinformatics solutions, positioning itself as a key player in large-scale genomics studies.

Company Market Share

Key players in the global market are heavily investing in advanced technologies to enhance their product offerings and expand their market presence. These companies are pursuing strategies such as collaborations, acquisitions, and partnerships to strengthen their portfolios and drive innovation.

10x Genomics: An Emerging Player in the market

10x Genomics is a prominent player in the single-cell analysis market, offering comprehensive solutions that integrate hardware, software, and chemistry to provide high-resolution insights into single-cell biology. Their Chromium platform is widely adopted for single-cell sequencing applications. In a strategic move, Illumina, a dominant gene-sequencing company, acquired Fluent BioSciences, a direct competitor to 10x Genomics, indicating the competitive dynamics in this market.

Recent Developments

In December 2024- 10x Genomics secured a permanent injunction against Bruker Corporation in a patent infringement lawsuit. The U.S. District Court for the District of Delaware ruled in favor of 10x Genomics, prohibiting Bruker from manufacturing, using, or selling its GeoMx Digital Spatial Profiler and related products in the United States. This injunction, set to take effect in January 2025, includes a provision allowing existing GeoMx users who installed the instrument before November 18, 2023.

List of Key and Emerging Players in Single Cell Bioinformatics Software and Services Market

10x Genomics

Illumina

Bio-Rad Laboratories

Fluidigm Corporation

Becton Dickinson (BD)

Qiagen

PerkinElmer

SAS Biosciences

Partek Incorporated

Seven Bridges Genomics

Key Industry Developments

May 2026

Parse Biosciences launched Trailmaker™, a cloud-native bioinformatics platform designed to simplify large-scale single-cell RNA sequencing analysis, enabling automated data processing, visualization, and collaboration for researchers.

April 2026

Illumina expanded its Connected Multiomics platform by integrating advanced single-cell bioinformatics workflows, providing streamlined analysis of genomics, transcriptomics, and multiomics datasets.

February 2026

10x Genomics introduced new software enhancements to its Cell Ranger and Loupe Browser platforms, improving single-cell data analysis, visualization, and interpretation for transcriptomics and immune profiling applications.

October 2025

QIAGEN expanded the capabilities of its CLC Genomics Workbench by introducing advanced bioinformatics tools for single-cell sequencing analysis, enabling improved cell clustering, differential expression analysis, and biomarker discovery.

Report Scope

Segmentation

By Product Type 2

Software Solutions
Services

By Applications 4

Oncology
Immunology
Neurology
Stem Cell Research

By Technology 3

Next-Generation Sequencing (NGS)
Mass Cytometry
Single-Molecule Real-Time (SMRT) Sequencing

By End-User 3

Academic Institutes
Pharmaceutical Companies
Contract Research Organizations (CROs)

Geographies Covered

North America 2

U.S.
Canada

Europe 8

U.K.
Germany
France
Spain
Italy
Russia
Nordic
Benelux

APAC 7

China
Korea
Japan
India
Australia
Taiwan
South East Asia

Middle East and Africa 6

UAE
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria

LATAM 5

Brazil
Mexico
Argentina
Chile
Colombia

Competitive Coverage 10x Genomics · Illumina · Bio-Rad Laboratories · Fluidigm Corporation · Becton Dickinson (BD)

Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The single cell bioinformatics software and services market size is valued at USD 1.58 Billion in 2026 and is projected to reach USD 4.04 Billion by 2034, at a CAGR of 12.4% during the forecast period 2026-2034.

North America dominated the market with a share of 42.5% in 2025.

The leading companies in this market are 10x Genomics, Illumina, Bio-Rad Laboratories, Fluidigm Corporation, Becton Dickinson.

The single cell bioinformatics software and services market is projected to grow at a CAGR of 12.4% during the forecast period of 2026 2034.

About the Author

Tejas Zamde

Research Analyst

Tejas Zamde is a market research professional with over two years of experience in the technology, semiconductor, electronics, and automotive sectors. He specializes in market assessment, competitive intelligence, industry analysis, market sizing, demand analysis, and strategic research.

His experience includes analyzing technology trends, market dynamics, regulatory developments, supply-demand patterns, value chains, and competitive landscapes across global and regional markets. He has supported clients with opportunity assessment, customer segmentation, competitive benchmarking, and growth strategy development.